240 related articles for article (PubMed ID: 1541831)
1. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon.
Zemmour J; Little AM; Schendel DJ; Parham P
J Immunol; 1992 Mar; 148(6):1941-8. PubMed ID: 1541831
[TBL] [Abstract][Full Text] [Related]
2. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
3. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
[TBL] [Abstract][Full Text] [Related]
4. Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition.
Matsui M; Moots RJ; Warburton RJ; Peace-Brewer AL; Tussey LG; Quinn DG; McMichael AJ; Frelinger JA
J Immunol; 1995 Feb; 154(3):1088-96. PubMed ID: 7822785
[TBL] [Abstract][Full Text] [Related]
5. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide.
Dong T; Boyd D; Rosenberg W; Alp N; Takiguchi M; McMichael A; Rowland-Jones S
Eur J Immunol; 1996 Feb; 26(2):335-9. PubMed ID: 8617300
[TBL] [Abstract][Full Text] [Related]
6. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
7. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.
Storkus WJ; Alexander J; Payne JA; Cresswell P; Dawson JR
J Immunol; 1989 Dec; 143(11):3853-7. PubMed ID: 2479694
[TBL] [Abstract][Full Text] [Related]
8. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
Wei ML; Cresswell P
Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
[TBL] [Abstract][Full Text] [Related]
9. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
10. Sequence and gene transfer analyses of HLA-CwBL18 (HLA-C blank) and HLA-Cw5 genes. Implications for the control of expression and immunogenicity of HLA-C antigens.
Tibensky D; DeMars R; Holowachuk EW; Delovitch TL
J Immunol; 1989 Jul; 143(1):348-55. PubMed ID: 2732471
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
[TBL] [Abstract][Full Text] [Related]
12. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line.
Greenwood R; Shimizu Y; Sekhon GS; DeMars R
J Immunol; 1994 Dec; 153(12):5525-36. PubMed ID: 7989754
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel HLA-B allele, HLA-B*3580, with possible implication in transplantation and CTL response.
Aureli A; Liberatore G; Papola F; Adorno D; Piancatelli D
Tissue Antigens; 2008 Jan; 71(1):90-1. PubMed ID: 17999652
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
[TBL] [Abstract][Full Text] [Related]
15. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
[TBL] [Abstract][Full Text] [Related]
17. MHC class I allorecognition: the likes and dislikes of CTL and NK cells.
Reinhardt C; Falk C; Steinle A; Schendel DJ
Behring Inst Mitt; 1994 Jul; (94):61-71. PubMed ID: 7998916
[TBL] [Abstract][Full Text] [Related]
18. Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TU165).
Uchańska-Ziegler B; Nössner E; Schenk A; Ziegler A; Schendel DJ
Eur J Immunol; 1993 Mar; 23(3):734-8. PubMed ID: 8449221
[TBL] [Abstract][Full Text] [Related]
19. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas.
Kawakami Y; Zakut R; Topalian SL; Stötter H; Rosenberg SA
J Immunol; 1992 Jan; 148(2):638-43. PubMed ID: 1729379
[TBL] [Abstract][Full Text] [Related]
20. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
Crowley NJ; Darrow TL; Quinn-Allen MA; Seigler HF
J Immunol; 1991 Mar; 146(5):1692-9. PubMed ID: 1671580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
